Oxford Immunotec Global Plc (OXFD) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oxford Immunotec Global Plc  (NASDAQ: OXFD)


Oxford Immunotec Global Plc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oxford Immunotec Global Plc's ROI in the third quarter of 2020?
Oxford Immunotec Global Plc recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter of 2020, resulting in a negative return on investment (ROI) of -8.52%.

Within the Healthcare sector 245 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 0 to 3116.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM -7.3 % 14.82 % 42.44 % 78.68 % 119.47 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 199 196 205 221 222
Return On Investment (TTM) -8.52 % -7.87 % -2.9 % -0.81 % 63.62 %
OXFD's Overall Ranking # 3116 # 0 # 0 # 0 # 81
Seq. Investment Change TTM -2.79 % -3.38 % -2.12 % 0.83 % 20.41 %
Seq. Net Income Change TTM - - - - 3.07 %
Net Income (TTM) in Millions -17 -17 -6 -2 141

OXFD Company Profile >> Back to OXFD Roi Comparisons >> See Annual OXFD Return On Investment



Return On Investment OXFD's Ranking
Within: No.
Industry # 7
Sector # 246
Overall # 3116

Return On Investment Statistics
High Average Low
94.37 %
-6.6 %
-45.76 %
(Dec 31 2018)   (Sep 30 2017)







Financial Statements
Oxford Immunotec Global Plc's III. Quarter Investments $ 199 Millions OXFD's Balance sheet
Oxford Immunotec Global Plc's III. Quarter Income $ 0 Millions Quarterly OXFD's Income Statement
OXFD's Income by Division See OXFD's Income by Division


OXFD Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 221 214 118 106 94
Y / Y Investment Growth 3.42 % 81.61 % 11.73 % 11.82 % 51.52 %
Net Income in Millions -2 121 -33 -22 -24
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.82 % 56.41 % -27.89 % -21.18 % -25.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OXFD's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OXFD's Competitors
Subscribers only: Roi for Oxford Immunotec Global Plc's Suppliers
Subscribers only: Return On Investment for OXFD's Customers

Other Ratios
OXFD's Roa OXFD's Inventory Turnover Ratio OXFD's Growth Rates OXFD's Dividend Statistics
OXFD's Profitability Ratios OXFD's Asset Turnover Ratio OXFD's Dividend Growth
OXFD's Roe OXFD's Valuation Ratios OXFD's Financial Strength Ratios OXFD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.